This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Trougakos, I. P. Articles by Gonos, E. S. Search for Related Content PubMed PubMed Citation Articles by Trougakos, I. P. Articles by Gonos, E. S.

Silencing Expression of the Clusterin/Apolipoprotein J Gene in Human Cancer Cells Using Small Interfering RNA Induces Spontaneous Apoptosis, Reduced Growth Ability, and Cell Sensitization to Genotoxic and Oxidative Stress

¹ Laboratory of Molecular and Cellular Aging, Institute of Biological Research and Biotechnology, National Hellenic Research Foundation, Athens, Greece, and ² Prostate Centre at Vancouver General Hospital, Division of Urology, University of British Columbia, Vancouver, British Columbia, Canada

Clusterin/Apolipoprotein J (CLU) is a heterodimeric ubiquitously expressed secreted glycoprotein that is implicated in several physiological processes and is differentially expressed in many severe physiological disturbances, including tumor formation and in vivo cancer progression. Despite extensive efforts, clarification of CLU’s biological role has been exceptionally difficult and its precise function remains elusive. Short RNA duplexes, referred to as small interfering RNAs (siRNAs), provide a new approach for the elucidation of gene function in human cells. Here, we describe siRNA-mediated CLU gene silencing in osteosarcoma and prostate human cancer cells and illustrate that CLU mRNA is amenable to siRNA-mediated degradation. Our data demonstrate that CLU knockdown in human cancer cells induces significant reduction of cellular growth and higher rates of spontaneous endogenous apoptosis. Moreover, CLU knockdown cancer cells were significantly sensitized to both genotoxic and oxidative stress induced by chemotherapeutic drugs and H₂O₂, respectively. These effects were more pronounced in cell lines that express high endogenous steady-state levels of the CLU protein and occur through hyperactivation of the cellular apoptotic machinery. Overall, our results reveal that, in the distinct cellular contexts of the osteosarcoma and prostate cancer cells assayed, CLU is a central molecule in cell homeostasis that exerts a cytoprotective function. The described CLU-specific siRNA oligonucleotides that can potently silence CLU gene expression may thus prove valuable agents during antitumor therapy or at other pathological conditions where CLU has been implicated.

This article has been cited by other articles:

				A. L. Yu, R. Fuchshofer, D. Kook, A. Kampik, H. Bloemendal, and U. Welge-Lussen Subtoxic Oxidative Stress Induces Senescence in Retinal Pigment Epithelial Cells via TGF-{beta} Release Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 926 - 935. [Abstract] [Full Text] [PDF]

				I. P. Trougakos, M. Lourda, M. H. Antonelou, D. Kletsas, V. G. Gorgoulis, I. S. Papassideri, Y. Zou, L. H. Margaritis, D. A. Boothman, and E. S. Gonos Intracellular Clusterin Inhibits Mitochondrial Apoptosis by Suppressing p53-Activating Stress Signals and Stabilizing the Cytosolic Ku70-Bax Protein Complex Clin. Cancer Res., January 1, 2009; 15(1): 48 - 59. [Abstract] [Full Text] [PDF]

				U. V. Jurkunas, M. S. Bitar, I. Rawe, D. L. Harris, K. Colby, and N. C. Joyce Increased Clusterin Expression in Fuchs' Endothelial Dystrophy Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 2946 - 2955. [Abstract] [Full Text] [PDF]

				H. Ammar and J. L. Closset Clusterin Activates Survival through the Phosphatidylinositol 3-Kinase/Akt Pathway J. Biol. Chem., May 9, 2008; 283(19): 12851 - 12861. [Abstract] [Full Text] [PDF]

				R. M. Moretti, M. M. Marelli, S. Mai, A. Cariboni, M. Scaltriti, S. Bettuzzi, and P. Limonta Clusterin Isoforms Differentially Affect Growth and Motility of Prostate Cells: Possible Implications in Prostate Tumorigenesis Cancer Res., November 1, 2007; 67(21): 10325 - 10333. [Abstract] [Full Text] [PDF]

				D. A. Sallman, X. Chen, B. Zhong, D. L. Gilvary, J. Zhou, S. Wei, and J. Y. Djeu Clusterin mediates TRAIL resistance in prostate tumor cells Mol. Cancer Ther., November 1, 2007; 6(11): 2938 - 2947. [Abstract] [Full Text] [PDF]

				J. Roman-Gomez, L. Cordeu, X. Agirre, A. Jimenez-Velasco, E. San Jose-Eneriz, L. Garate, M. J. Calasanz, A. Heiniger, A. Torres, and F. Prosper Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia Blood, April 15, 2007; 109(8): 3462 - 3469. [Abstract] [Full Text] [PDF]

				V. Devauchelle, A. Essabbani, G. De Pinieux, S. Germain, L. Tourneur, S. Mistou, F. Margottin-Goguet, P. Anract, H. Migaud, D. Le Nen, et al. Characterization and Functional Consequences of Underexpression of Clusterin in Rheumatoid Arthritis J. Immunol., November 1, 2006; 177(9): 6471 - 6479. [Abstract] [Full Text] [PDF]

				C. A. Casiano, M. Mediavilla-Varela, and E. M. Tan Tumor-associated Antigen Arrays for the Serological Diagnosis of Cancer Mol. Cell. Proteomics, October 1, 2006; 5(10): 1745 - 1759. [Abstract] [Full Text] [PDF]

				M. Zenkel, F. E. Kruse, A. G. Junemann, G. O. H. Naumann, and U. Schlotzer-Schrehardt Clusterin Deficiency in Eyes with Pseudoexfoliation Syndrome May Be Implicated in the Aggregation and Deposition of Pseudoexfoliative Material Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1982 - 1990. [Abstract] [Full Text] [PDF]

				A. So, S. Sinnemann, D. Huntsman, L. Fazli, and M. Gleave Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo Mol. Cancer Ther., December 1, 2005; 4(12): 1837 - 1849. [Abstract] [Full Text] [PDF]

				J. C. Mallory, G. Crudden, A. Oliva, C. Saunders, A. Stromberg, and R. J. Craven A Novel Group of Genes Regulates Susceptibility to Antineoplastic Drugs in Highly Tumorigenic Breast Cancer Cells Mol. Pharmacol., December 1, 2005; 68(6): 1747 - 1756. [Abstract] [Full Text] [PDF]

				X. Wang, N. Li, H. Li, B. Liu, J. Qiu, T. Chen, and X. Cao Silencing of Human Phosphatidylethanolamine-Binding Protein 4 Sensitizes Breast Cancer Cells to Tumor Necrosis Factor-{alpha}-Induced Apoptosis and Cell Growth Arrest Clin. Cancer Res., October 15, 2005; 11(20): 7545 - 7553. [Abstract] [Full Text] [PDF]

				T. Criswell, M. Beman, S. Araki, K. Leskov, E. Cataldo, L. D. Mayo, and D. A. Boothman Delayed Activation of Insulin-like Growth Factor-1 Receptor/Src/MAPK/Egr-1 Signaling Regulates Clusterin Expression, a Pro-survival Factor J. Biol. Chem., April 8, 2005; 280(14): 14212 - 14221. [Abstract] [Full Text] [PDF]

				A. Orlandi, S. Pucci, A. Ciucci, F. Pichiorri, A. Ferlosio, and L. G. Spagnoli Modulation of Clusterin Isoforms Is Associated With All-Trans Retinoic Acid-Induced Proliferative Arrest and Apoptosis of Intimal Smooth Muscle Cells Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 348 - 353. [Abstract] [Full Text] [PDF]

				M. Scaltriti, A. Santamaria, R. Paciucci, and S. Bettuzzi Intracellular Clusterin Induces G2-M Phase Arrest and Cell Death in PC-3 Prostate Cancer Cells1 Cancer Res., September 1, 2004; 64(17): 6174 - 6182. [Abstract] [Full Text] [PDF]

				Y. Bayon, M. A. Ortiz, F. J. Lopez-Hernandez, P. H. Howe, and F. J. Piedrafita The Retinoid Antagonist MX781 Induces Clusterin Expression in Prostate Cancer Cells via Heat Shock Factor-1 and Activator Protein-1 Transcription Factors Cancer Res., August 15, 2004; 64(16): 5905 - 5912. [Abstract] [Full Text] [PDF]